The 4 hour symposium, at the ISPNO conference on June 30, 2008, co-sponsored by the PLGA Foundation and the Brain Tumor Society, was a sell out success with over 500 researchers in attendance. This is the LARGEST single gathering of researchers/clinicians EVER to come together with the sole objective of discussing progress in the area of pediatric low grade gliomas.

20 research abstracts were presented from around the world and keynote speakers included Dr.Stiles, from Dana Farber Cancer Institute and Dr. Brennan from Memorial Sloane-Kettering Cancer Center.

In addition, an interdisciplinary panel of medical experts gathered together at the ISPNO Family Day, to speak with over 100 brain tumor families. Excerpts from these discussions can be viewed through the videos below:

At the July 2nd, 2008 International Society of Pediatric Neuro-Oncologists meeting in Chicago, more than 100 families with children suffering from brain tumors gathered to ask questions directed at an interdisciplinary panel of pediatric brain tumor physicians. In this short video, Dr. Packer shares with the audience some new advances in radiation therapy.

Can Cognitive Damage in Pediatric Brain Tumor Patients be Reversed?

Collateral damage to cognitive processes for a pediatric brain tumor patient are common due to the toxicity and invasive nature of current treatments. Unfortunately, scientific studies to better understand the impact of these treatments has historically been sparse.

At the July 2nd, 2008 International Society of Pediatric Neuro-Oncologists meeting in Chicago, more than 100 families with children suffering from brain tumors gathered to ask questions directed at an interdisciplinary panel of pediatric brain tumor physicians. In this short video, Dr. Packer shares with the audience some new insights into scientific studies targeted at reversing cognitive damage to pediatric brain tumor patients.

At the July 2nd, 2008 International Society of Pediatric Neuro-Oncologists meeting in Chicago, more than 100 families with children suffering from brain tumors gathered to ask questions directed at an interdisciplinary panel of pediatric brain tumor physicians. In this short video, Dr. Wong shares with the audience some of the new insights into treatment of hydrocephalus in pediatric brain tumor patients.

Immuno-vaccines are still very new to the brain tumor arena and historically have been focused on the adult brain tumor population. That being said, new advances suggest that there may be a higher likelihood that immuno-vaccines may be a treatment option in the future for children with brain tumors. At the July 2nd, 2008 International Society of Pediatric Neuro-Oncologists meeting in Chicago, more than 100 families with children suffering from brain tumors gathered to ask questions directed at an interdisciplinary panel of pediatric brain tumor physicians. In this short video, Dr. Kieran shares with the audience some of the new insights into potential immuno-vaccine treatments for pediatric brain tumor patients.

Finding less toxic and more effective treatments for children battling the most common forms of brain tumors will be possible through the collaboration of all interested parties. Most importantly, with the new-found spirit of collaboration between all medical disciplines as well as lay person resources (parent, families, caregivers, etc.) makes the possibility of finding these new treatments and a cure even more realistic. At the 2008 ISPNO meeting, more than 100 families with children suffering from brain tumors gathered to ask questions directed at an interdisciplinary panel of pediatric brain tumor physicians. In this short video, Dr. Roger Packer and Dr. Mark Kieran share with the audience some of their insights into potential for an accelerated pace of research based on the new, collaborative focus, of medical experts around the world.A Kid’s Brain Tumor Cure: Advances in Radiation (PLGA Foundation)

At the July 2nd, 2008 International Society of Pediatric Neuro-Oncologists meeting in Chicago, more than 100 families with children suffering from brain tumors gathered to ask questions directed at an interdisciplinary panel of pediatric brain tumor physicians. In this short video, Dr. Kieran shares a concise definition of the way a clinical trial protocol is structured and Dr. Goldman defines the three different Phases that a clinical trial can be registered.